A Randomized Feasibility Trial of a New Lifestyle Referral Assessment Versus Usual Assessment in an Acute Cardiology Setting.

J Cardiovasc Nurs

Kate Hill, PhD Senior Research Fellow, Leeds Institute of Health Sciences, University of Leeds, United Kingdom. Rebecca Walwyn, PhD Principal Statistician, Clinical Trials Research Unit, University of Leeds, United Kingdom. Diana Camidge, MSc Research Officer, Leeds Institute of Health Sciences, University of Leeds, United Kingdom. Jenni Murray, PhD Senior Research Fellow, Leeds Institute of Health Sciences, University of Leeds, United Kingdom. David Meads, MSc Associate Professor, Leeds Institute of Health Sciences, University of Leeds, United Kingdom. Greg Reynolds, FRCP Consultant Cardiologist, Leeds Teaching Hospitals Trust, Leeds, United Kingdom. Amanda Farrin, MSc Chair, Clinical Trials Research Unit, University of Leeds, United Kingdom. Allan House, DM Professor of Liaison Psychiatry, Leeds Institute of Health Sciences, University of Leeds, United Kingdom.

Published: April 2018

Background: A healthy diet, taking exercise, and not smoking or consuming alcohol in excess are important to reduce the risk of cardiovascular disease either alone or in combination with statin medication. Health education, including providing information to patients on healthy living and guidance on how to achieve it, is a key nursing function.

Objectives: This study aims first to assess the feasibility of conducting a full-scale trial of lifestyle referral assessment as shown by recruitment rate, data collection, and follow-up and second to assess proof of concept and explore possible mechanisms of change.

Methods: This was a single-center, randomized, 2-arm, parallel-group, unblinded feasibility trial conducted in an acute teaching hospital trust. Participants were followed up at 3 and 6 months after randomization.

Results: Eight hundred eighty-seven patients were screened for eligibility, of whom 132 (15%) were randomized into the trial. Of the patients allocated to the individualized assessment, 27% accepted referral or self-referred by 3 months in comparison to 5% allocated to the usual assessment.

Conclusions: We demonstrated that a full-scale trial is feasible and that an individualized approach increased the number of patients accepting referral to a formal program and initiating lifestyle change. However, we should consider the aim of the assessment and ways in which the process of change can be optimized in order to produce long-term benefit for patients.

Trial Registration: current controlled trials ISRCTN41781196.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743063PMC
http://dx.doi.org/10.1097/JCN.0000000000000294DOI Listing

Publication Analysis

Top Keywords

feasibility trial
8
trial lifestyle
8
lifestyle referral
8
referral assessment
8
full-scale trial
8
trial
5
assessment
5
randomized feasibility
4
referral
4
assessment versus
4

Similar Publications

Evidence on the effectiveness and implementation of mental health and psychosocial support (MHPSS) interventions for men in humanitarian settings is limited. Moreover, engagement and retention of men in such interventions has been challenging. Adaptations may therefore be required to improve the appropriateness and acceptability of these interventions for men.

View Article and Find Full Text PDF

Precision medicine using molecular-target drugs in psoriatic arthritis.

Ther Adv Musculoskelet Dis

January 2025

The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu 807-8555, Japan.

Psoriatic arthritis (PsA) presents various clinical manifestations, including skin lesions, peripheral arthritis, axial involvement, enthesitis, nail involvement, dactylitis, and uveitis. In addition, it causes a high incidence of lifestyle-related diseases and an increase in cerebrovascular and cardiovascular events. As the pathology of PsA has been clarified, molecular-targeted drugs targeting tumor necrosis factor-α, interleukin (IL)-17A, IL-17A/F, IL-17 receptor, IL-12/23(p40), IL-23p19, Cytotoxic T-lymphocyte Antigen-4 (CTLA-4), Janus kinase, and phosphodiesterase-4 have been developed and are widely used in clinical practice.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic led to widespread adoption of virtual communication platforms. Virtual study visits were implemented in the pilot cluster randomized trial (CRT) stage of Teen Adherence in KidnEy transplant Improving Tracking To Optimize Outcomes (TAKE-IT TOO). The present study aimed to understand study coordinators' perspectives on conducting a behavioral intervention with adolescent kidney transplant recipients using virtual conferencing platforms.

View Article and Find Full Text PDF

Objectives: Alcohol use disorder (AUD) is the most common substance use disorder in the United States. Despite availability of four FDA-approved medications, fewer than 10% of patients are prescribed medication. This study aimed to evaluate the impact and feasibility of emergency department (ED)-initiated oral naltrexone in patients with moderate to severe AUD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!